Rheumatology
News
COVID-19 vaccination in RMD patients: Safety data “reassuring”
Two studies show mainly mild reactions and favorable antibody responses in patients with rheumatic and musculoskeletal diseases after vaccination...
News
FDA warning letters target OTC cannabidiol product claims for pain relief
The FDA sent warning letters to two manufacturers for illegal marketing of drugs containing cannabidiol (CBD) and a failure to comply with current...
News
COVID-19’s impact on lupus inpatients examined in study
Younger inpatients with COVID-19 and SLE showed higher mortality than did COVID-19 inpatients of similar age from the general population in a...
News
Abdominal aortic calcification may further raise known fracture risk
Men with a prevalent vertebral fracture on lateral spine radiograph had even greater risk for future osteoporotic fractures with increasing...
Conference Coverage
Evidence grows for food as RA treatment
An enhanced anti-inflammatory diet shows promise for symptom reduction.
Conference Coverage
To improve psoriatic arthritis outcomes, address common comorbidities
Depression and obesity are associated with poor treatment response in PsA.
Conference Coverage
Novel lupus therapies take center stage
Speakers at the 2021 Rheumatology Winter Clinical Symposium spotlighted new drug approvals and new mechanisms of action in SLE, as well as...
News
RECOVERY trial of COVID-19 treatments stops colchicine arm
Recruitment was halted for lack of efficacy in patients hospitalized with the disease.
News
Tocilizumab (Actemra) scores FDA approval for systemic sclerosis–associated interstitial lung disease
The drug received FDA Priority Review and is the first biologic to be approved by the agency to reduce lung function decline in systemic sclerosis...
News
Telemedicine models show some benefit in OA
Two separate clinical trials evaluating remotely delivered interventions – one via smartphone app and one via telephone – had positive impacts on...